Target intelligence / Profile preview

Streptococcus mutans surface protein antigen (SpaP)

Target
SpaP
Molecular classification
Adhesin, Surface protein, Antigen I/II family
01

Overview

Streptococcus mutans surface protein antigen (SpaP), also known as Antigen I/II, is a 185-kDa cell surface adhesin and a primary virulence factor of the cariogenic bacterium Streptococcus mutans. It mediates the initial, sucrose-independent attachment of the bacteria to the acquired salivary pellicle on tooth surfaces by specifically binding to the host scavenger receptor glycoprotein GP340, also known as Deleted in Malignant Brain Tumors 1 (DMBT1). This interaction is a critical first step in the formation of dental plaque and the subsequent development of dental caries. Beyond its role in the oral cavity, SpaP has been implicated in the pathogenesis of infective endocarditis, as it facilitates bacterial adherence to damaged heart valves and vascular endothelium. Due to its central role in colonization, SpaP is a major target for the development of dental vaccines, monoclonal antibodies like Guy's 13, and anti-adhesive peptides such as p1025. However, a significant challenge in targeting SpaP is the potential for immunological cross-reactivity with human proteins, which necessitates careful design of therapeutic agents to avoid autoimmune responses.

Other names
Antigen I/IIAg I/IIPAcP1Antigen BSRIFMSL-1Surface protein A
02

Mechanism of action

Inhibition of bacterial adhesion to the salivary pellicle by blocking the interaction between SpaP and salivary agglutinin (gp340/DMBT1)

03

Biological functions

Cell adhesionBiofilm formationBacterial aggregationInterspecies interaction
04

Disease associations

Dental cariesInfective endocarditisBacteremia
05

Safety considerations

Immunological cross-reactivity with human heart tissuePotential disruption of the oral microbiome
06

Interacting drugs

Guy's 13

2 more in the full profile.

07

Biomarkers

spaP gene abundanceSalivary SpaP protein levels

Beyond the preview

Go deeper on Streptococcus mutans surface protein antigen (SpaP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus mutans surface protein antigen (SpaP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call